ReNeuron Group PLC (RQE.L)

Pharmaceuticals - Generic & Specialty

Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Share Price

0.0p (0.00%)
Bid: 1.8p Offer: 1.9p
As of: 29 Jun 2017 08:03
Market Capitalisation: £56.96 million
Shares In Issue: 3,164.62 million
PE: 0
Dividend Yield: 0

Share Performance

52 week high:   3.4p on 30-Nov-16
52 week low:   1.8p on 26-Jun-17

Financial History

to Mar '14to Mar '15to Mar '16
Operating Profit-£8m-£10m-£14m
Total Operating Expense£8m£10m£14m
Net Profit-£7m-£9m-£11m
Net Profit Before Taxes-£8m-£10m-£13m
Net Profit After Taxes-£7m-£9m-£11m

Sponsored by:

Company Information
Number of Shares Out 3,164.62m
Number of Shares Floating 3,037.44m
Number of Common Share Holders
Number of Employees 44
Key Figures
Volume (10 day Avg.) 3.70266m
Turnover £0.03m
Profit Before Tax £-11.35m
EPS -0.44p
Cashflow Per Share -0.43p
Cash Per Share 1.92p